Tiffany Madison
Internal Medicine · Roswell, GANPI 1841497054
Payments from drug & device makers
Across 306 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$908
- Novo Nordisk$584
- AstraZeneca$525
- AbbVie$487
- Takeda Pharmaceuticals U.S.A., Inc.$276
- Lilly USA, LLC$219
- plus $2K from 37 others
What the payments were for
- Food & beverage$4,96799%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,996 in reported general payments places this provider in the 85th percentile of 3,311 internal medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $18,982 |
| EliquisApixaban | 14 | $8,991 |
| SynthroidLevothyroxine Sodium | 11 | $1,163 |
| Atorvastatin Calcium | 63 | $708 |
| Levothyroxine Sodium | 35 | $440 |
| Amlodipine Besylate | 44 | $362 |
| Metformin Hcl ErMetformin Hcl | 28 | $284 |
| Gabapentin | 26 | $280 |
| Rosuvastatin Calcium | 19 | $245 |
| Olmesartan Medoxomil | 14 | $226 |
| Omeprazole | 15 | $222 |
| Trazodone Hcl | 16 | $162 |
| Donepezil Hcl | 17 | $150 |
| Tamsulosin Hcl | 13 | $129 |
| Lisinopril | 20 | $115 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $584 | $18,98219 claims |
| PfizerEliquis | $141 | $8,99114 claims |
| AbbVieSynthroid | $487 | $1,16311 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $30 | $44035 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Roswell
- Ognjenka Brkic VukoticRoswell$434K
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Charlotte Grayson-MathisFayetteville$9.6M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.